Substance abuse changes brain chemistry in ways that can trigger, worsen, or mimic nearly every major mental health condition. Around 21.2 million adults in the United States have both a substance use disorder and a mental illness at the same time, a pairing so common that clinicians refer to it as “co-occurring disorders.” The relationship runs in both directions: drugs and alcohol reshape the brain systems that regulate mood, fear, and motivation, while untreated mental health problems push people toward substances in an attempt to cope.
How Substances Rewire the Brain’s Reward System
Every addictive substance, regardless of its specific effects, shares one thing in common: it floods the brain’s reward pathway with dopamine. This pathway evolved to reinforce survival behaviors like eating and social bonding, but drugs hijack it. Cocaine and amphetamines block the recycling of dopamine at nerve endings, causing it to pile up. Opioids increase dopamine indirectly by silencing the neurons that normally keep dopamine cells in check. Alcohol and nicotine each trigger dopamine surges through their own routes, alcohol by acting on several receptor types at once, nicotine by directly stimulating receptors on dopamine-producing cells.
With repeated use, the brain adapts to these artificial surges by dialing down its own dopamine activity. Receptors become less sensitive, and the brain produces less dopamine on its own. The result is a state where everyday pleasures, a good meal, time with friends, a sense of accomplishment, no longer register the way they used to. This flattened reward response is one of the core reasons substance abuse so reliably leads to depression, apathy, and the inability to feel motivated without the drug.
Alcohol and Depression
Chronic alcohol use drives depression through multiple overlapping mechanisms. It triggers inflammation in the brain by activating immune cells and raising levels of inflammatory signaling molecules, creating a chemical environment strongly linked to low mood. Over time, alcohol disrupts the body’s stress-hormone system, leading to elevated cortisol and heightened sensitivity to stress, a hallmark feature of clinical depression.
Alcohol also reduces levels of a key protein that supports the growth and survival of brain cells. Lower levels of this protein impair the brain’s ability to form new connections, and the degree of reduction correlates with how severe depressive symptoms become. In mood-regulating regions like the hippocampus and prefrontal cortex, chronic drinking can actually kill neurons outright. On top of all this, alcohol recalibrates the brain’s calming neurotransmitter system so that when drinking stops, anxiety and agitation spike, which often drives people back to the bottle.
Cannabis and Psychosis Risk
Cannabis use, especially when it starts young and is frequent, meaningfully increases the risk of psychotic disorders. A landmark Swedish study found that people who had used cannabis by age 18 were 2.4 times more likely to later be diagnosed with schizophrenia, and a 27-year follow-up of the same group confirmed a dose-response relationship: the more often someone used cannabis, the higher the risk. A meta-analysis of six major long-term studies estimated that any cannabis use raised the odds of developing a psychotic disorder by about 40%, while the heaviest users faced roughly double the risk of non-users.
This doesn’t mean everyone who uses cannabis will develop psychosis. Genetic vulnerability plays a significant role, and most users never experience psychotic symptoms. But for those who are predisposed, regular cannabis use during adolescence and early adulthood appears to act as a trigger, particularly during a period when the brain is still developing.
Stimulants, Paranoia, and Psychosis
Methamphetamine and cocaine can produce psychotic episodes that look nearly identical to schizophrenia. The most common symptom is paranoia, which can progress from vague suspicion to fully formed delusions. Auditory and tactile hallucinations are also frequently reported, and violent behavior sometimes accompanies the paranoid thinking.
For most people, stimulant-induced psychosis resolves within about a week of stopping the drug. But it doesn’t always clear that quickly. Studies have found that roughly 16 to 17 percent of methamphetamine users who develop psychosis continue to experience symptoms after one to three months of abstinence, even among those with no family history of schizophrenia and no prior psychotic episodes. If psychotic symptoms persist beyond a month after the last use, clinicians begin considering whether the drug has unmasked a primary psychotic disorder rather than simply causing a temporary one.
Opioids and Emotional Dysregulation
Chronic opioid use reshapes the brain’s fear and emotion center, a structure called the amygdala, in ways that persist long after the drug leaves the system. During active use, opioids suppress this region, producing a sense of emotional calm. But the brain compensates by increasing the excitability of neurons in this area, so when opioids wear off, the amygdala essentially overreacts to everything.
This creates a state of heightened anxiety, dysphoria, and emotional reactivity during withdrawal and even during prolonged abstinence. The changes involve increased signaling of stress-related chemicals within the amygdala that connect to regions responsible for fear, motivation, and decision-making. The practical effect is that people in opioid recovery often find themselves unable to tolerate normal levels of stress, feeling emotionally raw in situations they would have handled easily before. This vulnerability is a major driver of relapse, because the drug becomes the only reliable way they know to silence the emotional noise.
The Self-Medication Cycle
The relationship between substance abuse and mental health isn’t just about drugs causing psychiatric symptoms. In the National Comorbidity Study, 51 percent of people who met criteria for a substance use disorder at some point in their lives also met criteria for a mental health disorder, and in the large majority of those cases, the mental health problem came first. This supports what clinicians call the self-medication hypothesis: people reach for substances because they’re trying to manage symptoms that feel unbearable, whether that’s anxiety, insomnia, emotional numbness, or intrusive thoughts.
Research from a national survey found that rates of illicit drug use increased among people with unmet mental health care needs. Among those with mental health problems, rates of drug use climbed alongside the severity of symptoms, even after excluding people who were already dependent on substances. Heavy alcohol use was lower among people who were actively receiving mental health treatment, suggesting that addressing the underlying condition can reduce the drive to self-medicate.
The cruel irony is that self-medication creates a feedback loop. Alcohol temporarily quiets anxiety but worsens it over weeks and months. Stimulants briefly lift depression but deplete the brain’s capacity for pleasure. Each cycle of temporary relief followed by worsening symptoms tightens the bond between the substance and the mental health problem until the two become deeply intertwined.
Withdrawal and Mental Health Symptoms
Stopping a substance after heavy use doesn’t bring immediate psychological relief. Withdrawal itself produces a wave of mental health symptoms that can be severe. Alcohol withdrawal causes anxiety, insomnia, and agitation, with severe cases progressing to hallucinations, seizures, and delirium. Benzodiazepine withdrawal is similar, producing anxiety, restlessness, irritability, poor concentration, and insomnia. Opioid withdrawal brings intense anxiety, insomnia, and a general sense of physical and emotional misery.
These symptoms can be difficult to distinguish from the underlying mental health conditions they resemble. Someone withdrawing from alcohol may look clinically indistinguishable from someone with a panic disorder. This overlap makes accurate diagnosis tricky in the early weeks of recovery, and it’s one reason clinicians often wait for acute withdrawal to pass before assessing whether a separate mental health condition exists underneath.
Suicide Risk
The most dangerous intersection of substance abuse and mental health is suicide. A recent meta-analysis found that people who misuse substances are 5.58 times more likely to die by suicide than the general population. The risk varies by substance: amphetamine misuse carried the highest risk at nearly 12 times the baseline rate, followed by opioids at about 5.5 times and cannabis at roughly 3.3 times. Even tobacco use was associated with a nearly twofold increase.
The risk was particularly elevated for women. Females who misused substances faced a suicide mortality rate over 12 times higher than controls, compared to about 5 times higher for males. This disparity may reflect the compounding effects of substance use on mental health conditions that are already more prevalent or more severe in women, though the exact reasons remain unclear. What is clear is that substance abuse doesn’t just worsen the daily experience of mental illness. It dramatically increases the likelihood of its most devastating outcome.